nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—Inflammation—Methylprednisolone—ankylosing spondylitis	0.0145	0.0145	CcSEcCtD
Plerixafor—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00968	0.00968	CcSEcCtD
Plerixafor—Inflammation—Methotrexate—ankylosing spondylitis	0.0096	0.0096	CcSEcCtD
Plerixafor—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00891	0.00891	CcSEcCtD
Plerixafor—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00889	0.00889	CcSEcCtD
Plerixafor—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00774	0.00774	CcSEcCtD
Plerixafor—Haemorrhage—Prednisolone—ankylosing spondylitis	0.0077	0.0077	CcSEcCtD
Plerixafor—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00712	0.00712	CcSEcCtD
Plerixafor—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.0071	0.0071	CcSEcCtD
Plerixafor—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Plerixafor—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Plerixafor—Abdominal distension—Prednisone—ankylosing spondylitis	0.00704	0.00704	CcSEcCtD
Plerixafor—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00694	0.00694	CcSEcCtD
Plerixafor—Erythema—Prednisolone—ankylosing spondylitis	0.0067	0.0067	CcSEcCtD
Plerixafor—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00646	0.00646	CcSEcCtD
Plerixafor—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00646	0.00646	CcSEcCtD
Plerixafor—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Plerixafor—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Plerixafor—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00622	0.00622	CcSEcCtD
Plerixafor—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Plerixafor—Erythema—Triamcinolone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Plerixafor—Erythema—Methylprednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Plerixafor—Malaise—Prednisolone—ankylosing spondylitis	0.00604	0.00604	CcSEcCtD
Plerixafor—Syncope—Prednisolone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Plerixafor—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Plerixafor—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Plerixafor—Discomfort—Prednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Plerixafor—Haemoglobin—Prednisone—ankylosing spondylitis	0.00562	0.00562	CcSEcCtD
Plerixafor—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Plerixafor—Haemorrhage—Prednisone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Plerixafor—Erythema—Dexamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Plerixafor—Erythema—Betamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Plerixafor—Malaise—Triamcinolone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Plerixafor—Malaise—Methylprednisolone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Plerixafor—Syncope—Triamcinolone—ankylosing spondylitis	0.00553	0.00553	CcSEcCtD
Plerixafor—Syncope—Methylprednisolone—ankylosing spondylitis	0.00552	0.00552	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.0055	0.0055	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Plerixafor—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00542	0.00542	CcSEcCtD
Plerixafor—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00541	0.00541	CcSEcCtD
Plerixafor—Shock—Prednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00529	0.00529	CcSEcCtD
Plerixafor—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00524	0.00524	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.0052	0.0052	CcSEcCtD
Plerixafor—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Plerixafor—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Plerixafor—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Plerixafor—Immune system disorder—Prednisone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Plerixafor—Malaise—Betamethasone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Plerixafor—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Plerixafor—Syncope—Betamethasone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Plerixafor—Syncope—Dexamethasone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Plerixafor—Shock—Triamcinolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Plerixafor—Shock—Methylprednisolone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Plerixafor—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Plerixafor—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Plerixafor—Erythema—Prednisone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Plerixafor—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Plerixafor—Discomfort—Betamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Plerixafor—Pain—Prednisolone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00458	0.00458	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—ankylosing spondylitis	0.00455	0.00455	CcSEcCtD
Plerixafor—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Plerixafor—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Plerixafor—Shock—Betamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Plerixafor—Shock—Dexamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Plerixafor—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Plerixafor—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Plerixafor—Malaise—Prednisone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Plerixafor—Syncope—Prednisone—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Plerixafor—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Plerixafor—Pain—Triamcinolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Plerixafor—Arthralgia—Prednisone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Plerixafor—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Plerixafor—Discomfort—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Plerixafor—Erythema—Methotrexate—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Plerixafor—Urticaria—Triamcinolone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Plerixafor—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Plerixafor—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Plerixafor—Shock—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Plerixafor—Pain—Betamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Plerixafor—Pain—Dexamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Plerixafor—Skin disorder—Prednisone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Plerixafor—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Plerixafor—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Plerixafor—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Plerixafor—Malaise—Methotrexate—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Plerixafor—Urticaria—Dexamethasone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Plerixafor—Dizziness—Prednisolone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Plerixafor—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Plerixafor—Insomnia—Prednisone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Plerixafor—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Plerixafor—Dyspepsia—Prednisone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Plerixafor—Arthralgia—Methotrexate—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Plerixafor—Rash—Prednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Plerixafor—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Plerixafor—Fatigue—Prednisone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Plerixafor—Headache—Prednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Plerixafor—Constipation—Prednisone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Plerixafor—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Plerixafor—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Plerixafor—Nausea—Prednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Plerixafor—Vomiting—Triamcinolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Plerixafor—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Plerixafor—Rash—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Plerixafor—Rash—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Plerixafor—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Plerixafor—Urticaria—Prednisone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Plerixafor—Headache—Triamcinolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Plerixafor—Headache—Methylprednisolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Plerixafor—Abdominal pain—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Plerixafor—Dizziness—Betamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Plerixafor—Nausea—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Plerixafor—Nausea—Methylprednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Plerixafor—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Plerixafor—Vomiting—Dexamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Plerixafor—Rash—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Plerixafor—Rash—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Plerixafor—Fatigue—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Plerixafor—Headache—Betamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Plerixafor—Headache—Dexamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Plerixafor—Asthenia—Prednisone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Plerixafor—Pain—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Plerixafor—Pruritus—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Plerixafor—Diarrhoea—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Plerixafor—Nausea—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Plerixafor—Urticaria—Methotrexate—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Plerixafor—Dizziness—Prednisone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Plerixafor—Vomiting—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Plerixafor—Rash—Prednisone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Plerixafor—Headache—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Plerixafor—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Plerixafor—Asthenia—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Plerixafor—Nausea—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Plerixafor—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Plerixafor—Dizziness—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Plerixafor—Vomiting—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Plerixafor—Rash—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Plerixafor—Dermatitis—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Plerixafor—Headache—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Plerixafor—Nausea—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
